Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of Calgary.

Ellen Lewis Sylvia McCulloch Etienne Mahe Nizar Bahlis Paola Neri Jason Tay Peter Duggan Victor H Jimenez-Zepeda

Clin Lymphoma Myeloma Leuk

Department of Medical Oncology and Hematology, Tom Baker Cancer Centre/University of Calgary, Calgary, AB, Canada; Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada. Electronic address:

Published: October 2023

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.clml.2023.07.004	DOI Listing

Publication Analysis

Top Keywords

presence t1114

t1114 patients

patients amyloidosis

amyloidosis treated

treated bortezomib-containing

bortezomib-containing regimens

regimens experience

experience amyloidosis

amyloidosis program

program calgary

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!